Skip to main content
Clinical Trials/NCT05649319
NCT05649319
Completed
N/A

Effectiveness of Enhanced Recovery After Surgery (ERAS) on Postoperative Recovery After Laparoscopic Distal Gastrectomy: An Open-labeled Randomized Controlled Study

Seoul National University Hospital1 site in 1 country98 target enrollmentFebruary 3, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Enhanced Recovery After Surgery
Sponsor
Seoul National University Hospital
Enrollment
98
Locations
1
Primary Endpoint
Change of the Quality of recovery-15 during the first 72 hours after surgery
Status
Completed
Last Updated
last year

Overview

Brief Summary

This prospective, randomized, open-labeled study is designed to evaluate the impact of enhanced recovery after surgery (ERAS) protocol on postoperative quality of recovery in patients undergoing laparoscopic distal gastrectomy. We hypothesize that our ERAS protocol can significantly improve the postoperative quality of recovery in patients with laparoscopic distal gastrectomy.

Detailed Description

Adult patients undergoing elective laparoscopic distal gastrectomy are randomly allocated to receive the ERAS protocol (n=49) or conventional protocol (n=49). The conventional groups receive our current perioperative management. The ERAS groups receive our new ERAS protocol including preoperative carbohydrate loading, shortening of perioperative fasting time, and multimodal opioid-sparing analgesia. The primary outcome measure was the postoperative quality of recovery evaluated using the Korean version of Quality of recovery-15 at 24, 48, and 72 hours postoperatively. The secondary outcome measures were pain intensity at rest and during coughing evaluated using an 11-point numeric rating scale at 24, 48, and 72 hours postoperatively, gastrointestinal dysfunction evaluated using the I-FEED score at 24, 48, and 72 hours postoperatively, the occurrence of postoperative nausea and vomiting during the first postoperative 24 hours, postoperative 24 to 48 hour period, and postoperative 48 to 72 hour period, the occurrence of major postoperative complications according to the Clavien-Dindo classification during hospitalization, and length of hospital stay.

Registry
clinicaltrials.gov
Start Date
February 3, 2023
End Date
August 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hojin Lee, MD, PhD

Professor

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled to undergo elective laparoscopic distal gastrectomy
  • American Society of Anesthesiologists (ASA)physical classification I-II
  • ECOG Performance Status Scale 0 or 1
  • Willingness and ability to sign an informed consent document

Exclusion Criteria

  • Patients with chronic pain
  • Gastrectomy with combined resection of other organs
  • Patients with history of upper abdominal surgery
  • Allergies to anesthetic or analgesic medications (fentanyl, ropivacaine, acetaminophen, NSAIDs)
  • Medical or psychological disease that can affect the treatment response

Outcomes

Primary Outcomes

Change of the Quality of recovery-15 during the first 72 hours after surgery

Time Frame: postoperative 24, 48, and 72 hours

Korean version of Quality of recovery-15 questionnaire (0-150): 0, "very poor recovery"; 150, "excellent recovery"

Secondary Outcomes

  • Postoperative pain score(postoperative 24, 48, and 72 hours)
  • Total fentanyl consumption(From the end of surgery to 24, 48, and 72 hours postoperatively)
  • Postoperative nausea and vomiting(From the end of surgery to 24, 48, and 72 hours postoperatively)
  • Postoperative gastrointestinal dysfunction(postoperative 24, 48, and 72 hours)
  • Recovery time(Evaluate every hour starting from 9A on the postoperative day 3 up to discharge)

Study Sites (1)

Loading locations...

Similar Trials